Company profile: Novosanis
1.1 - Company Overview
Company description
- Provider of medical devices enhancing accuracy of diagnostic tests and drug delivery, focused on prevention, detection and treatment of infectious diseases and oncology. Products include Colli-Pee, a urine collection device enabling volumetric, standardized first-void sampling to improve detection of infectious diseases and some cancers.
Products and services
- Medical Device Development and Production: Novosanis architects and fabricates Belgian-engineered devices that add value to diagnostic test accuracy across prevention, detection, and treatment in infectious diseases and oncology
- Colli-Pee: A first-void-specific urine collection device enabling volumetric, standardized sampling to improve detection of infectious diseases and some cancers by ensuring consistent sample volume
- Drug Delivery Devices: Novosanis develops and produces oncology-and-infectious-disease-focused medical devices adding value to drug delivery in the field of prevention, detection, and treatment of infectious diseases and oncology
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Novosanis
Sensile Medical
HQ: Switzerland
Website
- Description: Provider of liquid drug delivery devices and platforms developed in Switzerland, offering safe, cost-efficient, customizable on- and off-body solutions—featuring reusable and disposable concepts—for subcutaneous administration of biologics and small molecules, including Gx SensAir, on-body and belt-worn infusors with adjustable flow and connectivity, an inhalation assessment platform, and the Gx Inbeneo autoinjector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sensile Medical company profile →
PharmaJet
HQ: United States
Website
- Description: Provider of needle-free jet injection systems for fixed-dose intradermal, intramuscular, and subcutaneous vaccine delivery. Offerings include Tropis ID (0.1 ml intradermal), Stratis IM/SC (0.5 ml IM/SC with charging station), and platforms for nucleic acid, COVID-19 (e.g., ZyCoV-D), polio, and influenza (e.g., Afluria) vaccine delivery, enhancing cellular dispersion and immunogenicity and providing an alternative to needles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaJet company profile →
MannKind
HQ: United States
Website
- Description: Provider of inhaled and wearable therapeutic products and platforms for diabetes and pulmonary diseases, including Afrezza (inhaled insulin), Tyvaso DPI (treprostinil for PAH and PH-ILD), Clofazimine Inhalation Suspension (for NTM lung disease), Nintedanib DPI (for pulmonary fibrotic diseases), V-Go (wearable insulin delivery), and Technosphere Technology for dry powder inhalation formulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MannKind company profile →
Innocoll
HQ: United States
Website
- Description: Provider of targeted drug delivery solutions focused on biodegradable surgical implants and topically applied healthcare products, including XARACOLL, a resorbable collagen implant with bupivacaine for pain relief up to 24 hours after open inguinal hernia repair; POSIMIR, a single‑site bupivacaine injection providing relief up to 72 hours after arthroscopic subacromial decompression; the COLLARx collagen matrix platform; and CDMO services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Innocoll company profile →
ActivaTek
HQ: United States
Website
- Description: Provider of drug delivery and other medical devices, including iontophoretic products for the rehabilitation market. Manufacturer of ActivaDose dose controllers; ActivaDose II houses a 9-volt battery and features precise dosing, visual and audible displays, and dual channels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ActivaTek company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Novosanis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Novosanis
2.2 - Growth funds investing in similar companies to Novosanis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Novosanis
4.2 - Public trading comparable groups for Novosanis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →